Association between the metabolic syndrome and chronic kidney disease in Chinese adults
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The metabolic syndrome is a common risk factor for cardiovascular and chronic kidney disease (CKD) in Western populations. We examined the relationship between the metabolic syndrome and risk of CKD in Chinese adults. METHODS: A cross-sectional survey was conducted in a nationally representative sample of 15 160 Chinese adults aged 35-74 years. The metabolic syndrome was defined as the presence of three or more of the following risk factors: elevated blood pressure, low high density lipoprotein (HDL)-cholesterol, high triglycerides, elevated plasma glucose and abdominal obesity. CKD was defined as an estimated glomerular filtration rate<60 ml/min/1.73 m2 and elevated serum creatinine was defined as >or=1.14 mg/dl in men and >or=0.97 mg/dl in women (>or=95th percentile of serum creatinine in Chinese men and women aged 35-44 years without hypertension or diabetes, respectively). RESULTS: The multivariate-adjusted odds ratios [95% confidence interval (CI)] of CKD and elevated serum creatinine in participants with compared to those without the metabolic syndrome were 1.64 (1.16, 2.32) and 1.36 (1.07, 1.73), respectively. Compared to participants without any components of the metabolic syndrome, the multivariate-adjusted odds ratios (95% CI) of CKD were 1.51 (1.02, 2.23), 1.50 (0.97, 2.32), 2.13 (1.30, 3.50) and 2.72 (1.50, 4.93) for those with 1, 2, 3, and 4 or 5 components, respectively. The corresponding multivariate-adjusted odds ratios (95% CI) of elevated serum creatinine were 1.11 (0.88, 1.40), 1.39 (1.07, 2.04), 1.47 (1.06, 2.04) and 2.00 (1.32, 3.03), respectively. CONCLUSIONS: These findings suggest that the metabolic syndrome might be an important risk factor for CKD in Chinese adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768 · cited 1×
“In the US, diabetes and hypertension are the most common underlying causes of CKD [2,4].”
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710 · cited 1×
“The metabolic syndrome, characterized by a clustering of abdominal obesity, hypertriglyceridaemia, low high-density lipoprotein (HDL) cholesterol, elevated blood pressure (BP), and high fasting glucose, has been associated with an increased risk for the development of diabetes and CVD as well as an increased mortality…”
Human blood pressure determination by sphygmomanometry.
Perloff, D., Grim, C., Flack, J., Frohlich, E. D., Hill, M., McDonald, M., & Morgenstern, B. Z. (1993) · Circulation · doi:10.1161/01.cir.88.5.2460 · Cited by 1,591 · cited 1×
“During the clinical examination, BP and anthropometric measurements were collected by trained and certified observers using standard protocols and technique [12].”
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359 · cited 4×
“89-fold increased risk of CKD and microalbuminuria, respectively, in US adults [9].”
InfluentialSelf-citationChronic kidney disease: the global challenge
El Nahas, A. M., & Bello, A. K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17789-7 · Cited by 1,195
Prevalence of the metabolic syndrome and overweight among adults in China
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66375-1 · Cited by 917 · cited 2×
“These findings have important clinical and public health implications because the metabolic syndrome and CKD are becoming common in the Chinese general population [3,11].”
Self-citationRenal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
Muntner, P., He, J., Hamm, L., Loria, C., & Whelton, P. K. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133745 · Cited by 829
Self-citation
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.06.010 · Cited by 947
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.005 · Cited by 920
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000597 · Cited by 902
Self-citationObesity and chronic kidney disease
Jiang, Z., Wang, Y., Zhao, X., Cui, H., Han, M., Ren, X., Gang, X., & Wang, G. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2022 · Cited by 267
Insulin Resistance in Patients with Chronic Kidney Disease
Liao, M.-T., Sung, C.-C., Hung, K.-C., Wu, C.-C., Lo, L., & Lu, K.-C. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/691369 · Cited by 165
“The MetS and its components are associated with the development of CKD, microalbuminuria, and overt proteinuria [7, 8].”
BackgroundEvidence-based Practice Guideline for the Treatment of CKD
(2009) · Clinical and Experimental Nephrology · doi:10.1007/s10157-009-0237-8 · Cited by 129
Nerpin, E., Risérus, U., Ingelsson, E., Sundström, J., Jobs, M., Larsson, A. O., Basu, S., & Ärnlöv, J. (2008) · Diabetes Care · doi:10.2337/dc08-0369 · Cited by 126
“Also, insulin sensitivity is associated with several glucometabolic factors, cardiovascular risk factors and lifestyle factors that have been shown to be associated with a reduced GFR and the development of chronic kidney disease (2; 12; 21-23).”
BackgroundMetabolic syndrome and renal disease
Gluba-Brzózka, A., Mikhailidis, D. P., Lip, G. Y. H., Hannam, S., Rysz, J., & Banach, M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.013 · Cited by 121
Obesity, metabolic health, and the risk of end-stage renal disease
Panwar, B., Hanks, L. J., Tanner, R. M., Muntner, P., Kramer, H., McClellan, W. M., Warnock, D. G., Judd, S. E., & Gutiérrez, O. M. (2015) · Kidney International · doi:10.1038/ki.2014.384 · Cited by 104
Self-citationRisk of end-stage renal disease associated with gout: a nationwide population study
Yu, K., Kuo, C., Luo, S., See, L., Chou, I., Chang, H.-C., & Chiou, M. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3806 · Cited by 112
“Proteinuria [23], hypertension [24], hyperglycemia [25], and metabolic syndrome [26] are well-documented risk factors for CKD and are fairly common in patients with gout.”
BackgroundPPARs and the kidney in metabolic syndrome
Ruan, X. Z., Zheng, F., & Guan, Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00152.2007 · Cited by 111
Is Serum Cystatin-C a Reliable Marker for Metabolic Syndrome?
Servais, A., Giral, P., Bernard, M., Bruckert, É., Deray, G., & Bagnis, C. I. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.040 · Cited by 104
Impact of Obesity in Kidney Diseases
Kotsis, V., Martínez, F., Trakatelli, C., & Redón, J. (2021) · Nutrients · doi:10.3390/nu13124482 · Cited by 100
“[15] 15,160 Chinese adults chronic kidney disease 1.”
BackgroundRelationship between chronic kidney disease and metabolic syndrome: current perspectives
Nashar, K., & Egan, B. M. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s45183 · Cited by 93
“03) respectively.(26) The Strong Heart Study enrolled 1,484 Native Americans without diabetes between 1988 and 1999.”
BackgroundMetabolic syndrome in hypertensive patients: An unholy alliance
Mulè, G., Calcaterra, I., Nardi, E., Cerasola, G., & Cottone, S. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i9.890 · Cited by 90
Overweight, Obesity and Chronic Kidney Disease
Ting, S. M. S., Nair, H., Ching, I., Taheri, S., & Dasgupta, I. (2009) · Nephron Clinical Practice · doi:10.1159/000214206 · Cited by 88
Metabolic Syndrome and Kidney Disease
Ritz, E. (2008) · Blood Purification · doi:10.1159/000110566 · Cited by 84
“CKD is predicted not only by obesity and visceral obesity. A correlation also exists between the number of the components of the MS and the prevalence of microalbuminuria and of CKD [”
BackgroundLin, B., Shao, L., Luo, Q., Ou-yang, L., Zhou, F., Du, B., He, Q., Wu, J., Xu, N., & Chen, J. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-36 · Cited by 79
“Metabolic diseases such as diabetes, obesity and hypertension are know n to be risk factors of kidney injury, and play an important role in the progressi on of CKD [4-6].”
BackgroundSelf-citationObesity, insulin resistance and kidney disease risk: insights into the relationship
Sarafidis, P. A. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328305b994 · Cited by 70
Metabolic syndrome and chronic kidney disease
Ruan, X. Z., & Guan, Y. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00042.x · Cited by 68
Yu, M., Ryu, D., Kim, S., Choi, K.-B., & Kang, D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp483 · Cited by 68
Raimundo, M. R., & Lopes, J. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/747861 · Cited by 64
“Almost all of them found a significant association between MS and CKD and consistently demonstrated an increased risk parallel to the number of MS traits [68, 74, 77, 79].”
BackgroundAlizadeh, S., Ahmadi, M., Nejad, B. G., Djazayeri, A., & Shab‐Bidar, S. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13201 · Cited by 61
Cao, X., Zhou, J., Yuan, H., Wu, L., & Chen, Z. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0083-8 · Cited by 61
“org/publicdomain/zero that metabolic syndrome is associated with an increased risk of CKD [6–8].”
BackgroundDing, C., Yang, Z., Wang, S., Sun, F., & Zhan, S. (2018) · Endocrine · doi:10.1007/s12020-018-1552-1 · Cited by 53
“Unlike previous studies in which central obesity was the MetS component with the strongest association with CKD [32, 33], we found that dyslipidemia (including elevated TG and a low HDL-C level) was the most strongly associated Table 5 Hazard ratios associated MetS for hypertension, T2DM, and CKD Outcomes Hazard ratio…”
ResultRole of NADPH Oxidase in Metabolic Disease‐Related Renal Injury: An Update
Wan, C., Su, H., & Zhang, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7813072 · Cited by 52
Gao, R.-Y., Hsu, B., Wu, D., Hou, J.-S., & Chen, M. (2019) · International Journal of Endocrinology · doi:10.1155/2019/5163245 · Cited by 52
Zomorrodian, D., Rad, A. K., Avan, A., Ebrahimi, M., Nematy, M., Azarpazhooh, M. R., Emamian, M., Sadeghzade, M., Mirhafez, S. R., Mohammadi, M., et al. (2015) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2014-205160 · Cited by 48
Zhang, H., Zhu, S., Chen, J., Tang, Y., Hu, H., Mohan, V., Radha, V., Wang, J., & Chen, H. (2012) · Diabetes Care · doi:10.2337/dc11-2142 · Cited by 50
“The study of these models has confirmed that PPARg plays a key role in regulating insulin sensitivity (33,34), which has been proved to be closely associated with glomerular filtration rate and albuminuria (35).”
BackgroundSelf-citationWaist-to-height ratio is the best index of obesity in association with chronic kidney disease
Lin, C., Chou, C., Lin, C., Huang, C., Liu, C.-S., & Lai, S. (2007) · Nutrition · doi:10.1016/j.nut.2007.08.007 · Cited by 45
Jang, S. Y., Kim, I., Ju, E. Y., Ahn, S. J., Kim, D., & Lee, S. W. (2010) · Journal of Public Health · doi:10.1093/pubmed/fdp127 · Cited by 43
Liao, C.-T., Kao, T., Chou, Y., Wu, M., Chen, Y., Chuang, H.-F., Hung, K., Chu, T., Wu, K., & Tsai, T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr175 · Cited by 41
“Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD) and endstage renal disease (ESRD) requiring dialysis therapy [1].”
BackgroundInfluentialChen, S., Liu, H., Liu, X., Li, Y., Li, M., Liang, Y., Shao, X., Holthöfer, H., & Zou, H. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000355718 · Cited by 41
Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals
Johns, B., Pao, A. C., & Kim, S. H. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr498 · Cited by 41
“Recent studies have suggested that individuals with metabolic syndrome are at increased risk for developing chronic kidney disease (CKD) [1–4].”
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 41
Vigil, L., Lopez, M., Condés, E., Varela, M. G., Lorence, D., Carretero, R. G., & Ruiz, J. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.01.002 · Cited by 38
Ming, J., Xu, S., Yang, C., Gao, B., Wan, Y., Xing, Y., Zhang, L., Yang, W., & Ji, Q. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.004 · Cited by 37
“3%) on the data from the InterASIA study [13].”
BackgroundMethodResultInfluentialSong, Y., Sung, J., & Lee, K. (2015) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1083-5 · Cited by 38
Impact of metabolic syndrome on the incidence of chronic kidney disease: A Chinese cohort study
Yang, T., Chu, C., Hsu, C., Hsieh, P.-C., Chung, T.-C., Bai, C., You, S., Hwang, L., Lin, C.-M., & Sun, C. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01607.x · Cited by 36
“In addition, studies on this topic conducted in Japan also indicated that MetS was a significant determinant of CKD in Japanese.(12,23) Likewise, Chen et al.”
BackgroundZammit, A. R., Katz, M. J., Derby, C. A., Bitzer, M., & Lipton, R. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139369 · Cited by 34
Song, H., Wang, X., Cai, Q., Ding, W., Huang, S., & Zhuo, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113450 · Cited by 31
“A similar study [9] performed on 19,012 Chinese populations aged 35 to 74 years revealed that the OR of the elevated serum creatinine with MetS was 1.”
BackgroundMethodInfluentialObara, N., Yamagishi, S., Taguchi, K., Kaida, Y., Yokoro, M., Nakayama, Y., Ando, R., Asanuma, K., Matsui, T., Ueda, S., et al. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1265-9 · Cited by 31
Renal damage in the metabolic syndrome (MetSx): Disorders implicated
Joyce, T., Chirino, Y. I., Martínez‐Tagüeña, N., & Pedraza‐Chaverrí, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.032 · Cited by 31
Charradi, K., Elkahoui, S., Karkouch, I., Limam, F., Hamdaoui, G., Hassine, F. B., May, M. V. E., May, A. E., & Aouani, E. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0416 · Cited by 31
“bility to chronic kidney diseases (Chen et al. 2007), or with the impact of dyslipidemia on the progression of chronic kidney diseases (Kasiske et al.”
BackgroundChuang, S., Shih, H., Chien, M.-N., Liu, S.-C., Wang, C., & Lee, C. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.022 · Cited by 30
Self-citationMetabolic syndrome in peritoneal dialysis patients
Li, P. K.-T., Kwan, B. C., Szeto, C., & Ko, G. T. C. (2008) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfn073 · Cited by 30
“5% in those with five components of MES as defined by the NCEP criteria [54].”
BackgroundGhazizadeh, H., Fazilati, M., Pasdar, A., Avan, A., Tayefi, M., Ghasemi, F., Mehramiz, M., Mirhafez, S. R., Ferns, G. A., Azimi–Nezhad, M., et al. (2016) · Gene · doi:10.1016/j.gene.2016.10.034 · Cited by 29
“There is growing body of data showing the association of MetS with insulin resistance, diabetes, CVD and chronic kidney diseases (CKD) (Tanaka et al., 2006; Chen et al., 2007; Agarwal et al., 2012; Gu et al., 2005; Kitiyakara et al., 2007).”
BackgroundInfluentialMetabolic Syndrome and Renal Injury
Sheen, Y., & Sheu, W. H. (2011) · Cardiology Research and Practice · doi:10.4061/2011/567389 · Cited by 28
“Study Ethnicity Adjusted risk factors OR (95% CI) (6) Tanaka et al. 2006 [25] Japanese Age + 1.54 (1.28–1.85)Sex + HTN DM (7) Chen et al. 2007 [26] Chinese adults Age + 1.64 (1.16–1.32)Sex + HTN DM (8) Hao et al. 2007 [27] Japanese Age + 1.99 (1.49–2.66)Sex + HTN DM (9) Rashidi et al. 2007 [28]…”
BackgroundInfluentialMetabolic syndrome and chronic kidney disease
Bhowmik, D. M., & Tiwari, S. (2008) · Indian Journal of Nephrology · doi:10.4103/0971-4065.41279 · Cited by 28
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
Khasanova, A. K., Добродеева, В. С., Shnayder, N. A., Петрова, М. М., Пронина, Е., Николаевна, Б. Е., Ларева, Н. В., Garganeeva, N. P., Smirnova, D. A., & Nasyrova, R. F. (2022) · Metabolites · doi:10.3390/metabo12080726 · Cited by 26
Carbone, F., Mach, F., Pontremoli, R., Viazzi, F. C., & Montecucco, F. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0499 · Cited by 26
“Five studies included United States or European populations (88-91, 101), whereas nine studies included Asian populations (92-100).”
BackgroundKovács, T., Vas, T., Kovesdy, C. P., Késői, I., Sági, B., Wittmann, I., & Nagy, J. (2012) · Clinical Kidney Journal · doi:10.1093/ckj/sfs131 · Cited by 26
“64 in the InterAsia study [26], 1.”
Obesity and metabolic syndrome–related chronic kidney disease in nondiabetic, nonhypertensive adults
Yoon, Y. S., Park, H. S., Yun, K. E., & Kim, S. B. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.029 · Cited by 26
Ghazizadeh, H., Rezaei, M., Avan, A., Fazilati, M., Pasdar, A., Tavallaie, S., Kazemi, E., Seyedi, S. M. R., Ferns, G. A., Azimi–Nezhad, M., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05081-2 · Cited by 25
Serum creatinine levels and risk of metabolic syndrome in a middle-aged and older Chinese population
Wang, J., Li, X., Han, X., YANG, K. Y., Liu, B., Li, Y., Wu, P., Liu, X., Yu, K., Dai, X., et al. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.11.025 · Cited by 25
Satirapoj, B., Supasyndh, O., Nata, N., Phulsuksombuti, D., Utennam, D., Kanjanakul, I., Choovichian, P., & Duangurai, K. (2010) · PubMed · Cited by 25
Kubrusly, M., de Oliveira, C. M. C., Simões, P. S. F., Lima, R. D. O., Galdino, P. N. R., Sousa, P. D. A. F., & Jerônimo, A. L. C. (2015) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20150011 · Cited by 24
Liu, C., & Li, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6916 · Cited by 24
“Clinical statistics have shown that chronic kidney disease (CKD) ranks third in the world, in terms of incidence rate and number of infected individuals, next to cancer and heart diseases (1,2).”
BackgroundConséquences rénales de l’obésité
Laville, M. (2011) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2010.11.007 · Cited by 24
Epidemiology of hypertension and chronic kidney disease in China
Chen, J. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328337f921 · Cited by 24
Self-citationFakhrzadeh, H., Ghaderpanahi, M., Sharifi, F., Badamchizade, Z., Mirarefin, M., & Larijani, B. A. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000274046 · Cited by 24
Association between waist‐to‐hip ratio and chronic kidney disease in the elderly
Chou, C., Lin, C.-H., Lin, C., Huang, C., Liu, C. ‐., & Lai, S. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01587.x · Cited by 23
Metabolic syndrome and its components associated with chronic kidney disease
Rashidi, N., Maleki, A., Montazeri, M., Montazeri, M., & Abdolmaleki, E. Y. (2015) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.163969 · Cited by 23
“Our finding was consistent with studies that concluded that low HDL and high TG levels had association with CKD and appeared to be a risk factor for developing CKD[5,31,33] whereas inconsistent with the aforementioned studies in China,[32] Japan,[10] and Nigeria.”
ResultInfluentialHeo, N. J., Ahn, J. M., Lee, T. W., Chin, H. J., Na, K. Y., Chae, D., & Kim, S. (2010) · Hypertension Research · doi:10.1038/hr.2010.39 · Cited by 23
Liu, D., Jia, W. A. N., Liu, Z., Pei, W. A. N. G., Cheng, G., & Shi, X. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20121642 · Cited by 23
“Additional new reports on the positive relationship between high TG and CKD were demonstrated in studies of metabolic syndrome and chronic kidney disease.(29,30)”
BackgroundMetabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population.
Satirapoj, B., Supasyndh, O., Mayteedol, N., Chaiprasert, A., & Choovichian, P. (2011) · PubMed · Cited by 22
Pan, B., & Loke, S.-S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190985 · Cited by 22
See, L., Kuo, C.-F., Yu, K.-H., & Shen, Y.-M. (2014) · Biomedical Journal · doi:10.4103/2319-4170.132886 · Cited by 21
“14), and metabolic syndrome([27]) (ORs: 1.”
Factors Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes in Bangladesh
Islam, S. M. S., Salehin, M., Zaman, S. B., Tansi, T., Gupta, R. D., Barua, L., Banik, P. C., & Uddin, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312277 · Cited by 20
“Hypertension is a classical risk factor of kidney injury, and uncontrolled hypertension plays an important role in the progression of CKD by increasing glomerular filtration pressure and subsequent renal damage [39].”
BackgroundCao, X., Xie, X., Zhou, J., Yuan, H., & Chen, Z. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0805-z · Cited by 19
“Some studies involving Malays [12] and Japanese men [13] have reported an association between BP and CKD, and some studies involving Chinese [14], Japanese [15], and Korean adults [16] have documented no significant association between BP and CKD.”
ResultInfluentialCao, Y., Sun, G., Liu, R., Sun, A., Zhang, Q., Yang, L., Wang, L., Chao, X., Zhou, X., Zhang, S., et al. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1655451 · Cited by 19
Metabolic Syndrome: An Emerging Threat to Renal Function
Ritz, E. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02350607 · Cited by 19
“China (20), and Thailand (21) document the same relationship.”
BackgroundImpact of Dietary Patterns on Metabolic Syndrome in Young Adults: A Cross-Sectional Study
Liu, J., Lu, W., Lv, Q., Wang, Y., Xu, X., He, Y., Chang, H., Zhao, Y., Zhang, X., Zang, X., et al. (2024) · Nutrients · doi:10.3390/nu16172890 · Cited by 18
“Metabolic syndrome is a clinical syndrome characterized by abdominal obesity, hypertriglyceridemia, low high-density lipoprotein cholesterol, elevated blood pressure, and increased fasting blood glucose [1].”
BackgroundMetabolic syndrome and chronic kidney disease in a rural Chinese population
Jiang, L., Liang, Y., Qiu, B., Wang, F., Duan, X., Yang, X., Yang, J., Huang, W., & Wang, N. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.07.014 · Cited by 18
Kim, C. S., Choi, J. S., Bae, E. H., Kwon, S., Ahn, Y., Jeong, M. H., Kim, Y. J., Cho, M., Kim, C. J., & Kim, S. W. (2012) · Metabolism · doi:10.1016/j.metabol.2012.11.002 · Cited by 18
“[19] Chen J, Gu D, Chen CS, et al.”
BackgroundKelishadi, R., Gheissari, A., Bazookar, N., Motlagh, M. E., Taslimi, M., & Ardalan, G. (2013) · PubMed Central · Cited by 16
Deibert, P., Lutz, L., König, D., Zitta, S., Meinitzer, A., Vitolins, M. Z., Becker, G., & Berg, A. (2011) · PubMed · Cited by 16
Ferraro, P. M., Lupo, A., Yabarek, T., Graziani, M. S., Bonfante, L., Abaterusso, C., & Gambaro, G. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0040 · Cited by 15
“6 7–9 To the best of our knowledge, the issue has been investigated in European populations in only two reports, with inconsistent results.”
Sabanayagam, C., Teo, B. W., Tai, E. S., Jafar, T. H., & Wong, T. Y. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-86 · Cited by 15
“However, similar to our findings in Chinese and Indians, three cross-sectional studies involving Chinese [20], and Japanese [21,47] adults reported no significant association between systolic BP and CKD.”
ResultRayyan‐Assi, H., Ziv, A., & Dankner, R. S. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3121 · Cited by 15
Tsao, Y.-C., Li, W.-C., Yeh, W.-C., Ueng, S. W., Chiu, S. Y., & Chen, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238958 · Cited by 15
“Metabolic syndrome was suggested to be an important risk factor for chronic kidney disease [40]; however, other studies have suggested that low serum creatinine is a predictor of type 2 DM and metabolic syndrome [41].”
ResultSelf-citationChanges in waist circumference and incidence of chronic kidney disease
Barzin, M., Hosseinpanah, F., Serahati, S., Salehpour, M., Nassiri, A. A., & Azizi, F. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12253 · Cited by 15
Metabolic syndrome and chronic kidney disease
Belarbia, A., Nouira, S., SAHTOUT, W., Guedri, Y., & Achour, A. (2015) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.164573 · Cited by 14
Metabolic syndrome component combinations and chronic kidney disease: The severance cohort study
Cho, J. A., Lee, S. J., Reid, E. A., & Jee, S. H. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.02.006 · Cited by 13
Prasad, N., Sinha, A., Gupta, A. K., Sharma, R. K., Kaul, A., BHADAURIA, D. S., & Ranagswamy, D. (2013) · Nephrology · doi:10.1111/nep.12124 · Cited by 13
Cao, C., Wan, X. H., Chen, Y., & Wu, W. (2009) · Renal Failure · doi:10.1080/08860220902963822 · Cited by 13
Liu, P., Ma, F., Lou, H., & Zhu, Y. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000306 · Cited by 13
Stengel, B., Jaussent, I., Guiserix, J., Bourgeon, B., Papoz, L., & Favier, F. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.10.002 · Cited by 14
Boronat, M., Bosch, E., Lorenzo-Villegas, D. L., Quevedo, V., López-Ríos, L., Riaño, M., Delgado, Y. G., & García-Cantón, C. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1117904 · Cited by 12
“73 m(2).(3,4) More importantly, a considerable number of prospective”
BackgroundDimitrijević, Z., Jovanović, A., Cvetković, M., Vrecic, T., Kostić, E. N., & Mitić, B. (2019) · Medicina · doi:10.3390/medicina55100694 · Cited by 12
“The female gender dominance seen in our data is similar to several other studies [31,33,34].”
ResultDheir, H., Özkahya, M., Kırçelli, F., Demirci, M. S., Aşçı, G., Töz, H., Ertilav, M., Köse, T., & Ok, E. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.8350 · Cited by 11
Azimi–Nezhad, M., Mirhafez, S. R., Stathopoulou, M. G., Murray, H. A., Ndiaye, N. C., Bahrami, A., Varasteh, A., Avan, A., Bonnefond, A., Rancier, M., et al. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.03.009 · Cited by 11
IL-18 Mediates Vascular Calcification Induced by High-Fat Diet in Rats With Chronic Renal Failure
Zhang, Y., Zhang, K., Zhang, Y., Zhou, L., Huang, H., & Wang, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.724233 · Cited by 11
“And at the same time, the four factors affect each other, forming a vicious circle (12, 13).”
BackgroundMetabolic Syndrome and Mild to Moderate Chronic Kidney Disease Among Minorities
Navaneethan, S. D., Schold, J. D., & Srinivas, T. R. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.10.008 · Cited by 11
Zammit, A. R., Katz, M. J., Derby, C. A., Bitzer, M., & Lipton, R. B. (2015) · Cardiorenal Medicine · doi:10.1159/000441624 · Cited by 11
Association of metabolic syndrome and IgA nephropathy
Wang, L., Zhang, Y., Chen, S., Chen, J., Zhuang, Y., & Chen, J. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.074278 · Cited by 11
Self-citation
Metadata
- Authors
- Chen, J., Gu, D., Chen, C.-S., Wu, X., Hamm, L. L., Muntner, P., Batuman, V., Lee, C.-H., Whelton, P. K., & He, J.
- Affiliations
- Tulane University (US)
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-25
- Volume
- 22
- Issue
- 4
- Pages
- 1100-1106
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2150827260
- Cited by
- 164
- References
- 20
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 15 · 2017: 11 · 2016: 8 · 2015: 13 · 2014: 12 · 2013: 14 · 2012: 7
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK60963, U01DK060963)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD043451)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic syndrome, chronic kidney disease, creatinine elevation, risk factors, Chinese adults, hypertension, low HDL cholesterol, hypertriglyceridemia, hyperglycemia, abdominal obesity, estimated glomerular filtration rate
- MeSH terms
- Adult, Aged, Blood Glucose, China, Chronic Disease, Creatinine, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Kidney Diseases, Male, Middle Aged, Obesity, Risk Factors, Body Mass Index, Multivariate Analysis, Odds Ratio, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.